Cholesterol Metabolism: Understanding Endogenous Pathways with Simple Animations

The liver is the primary site of cholesterol synthesis, producing about eighty percent of the body's cholesterol.Inside a liver cell, cholesterol synthesis occurs through a complex series of enzymatic reactions.The process begins with Acetyl-CoA, a simple molecule derived from cellular metabolism.Through several enzymatic steps, Acetyl-CoA is converted to HMG-CoA.The rate-limiting step of cholesterol synthesis is catalyzed by HMG-CoA reductase, converting HMG-CoA to mevalonate.Through additional steps, mevalonate is ultimately converted into cholesterol.The entire process is regulated by SREBP proteins, which control the expression of synthesis enzymes.When cholesterol levels rise, a feedback mechanism inhibits SREBP, reducing synthesis.As cellular cholesterol levels increase, the synthesis rate decreases exponentially through this negative feedback loop.This tightly regulated synthesis process ensures the liver produces appropriate amounts of cholesterol to meet the body's needs.The liver packages cholesterol and triglycerides into very low-density lipoproteins, or VLDL.VLDL particles contain ApoB protein, which is essential for their assembly and secretion.As VLDL travels through the bloodstream, it delivers triglycerides to tissues and gradually transforms into LDL.This transformation results in a smaller, more cholesterol-rich LDL particle.LDL particles bind to specific receptors on cell surfaces through their ApoB protein.Meanwhile, HDL particles, containing ApoA1 protein, are also released by the liver.HDL performs reverse cholesterol transport, collecting excess cholesterol from tissues and returning it to the liver.The cholesterol-rich HDL then returns to the liver, where the cholesterol can be recycled or converted to bile acids.Apolipoproteins play crucial roles in directing lipoprotein traffic and metabolism.This transport system maintains cholesterol balance between tissues.Cells maintain cholesterol homeostasis through a complex system of sensors and regulators.LDL receptors on the cell surface bind to LDL particles, allowing cells to take up cholesterol from the bloodstream.When LDL particles bind to these receptors, they are internalized through endocytosis.Inside the nucleus, SREBP proteins act as cholesterol sensors, controlling the expression of genes involved in cholesterol metabolism.When cholesterol levels rise, LXR nuclear receptors are activated, triggering mechanisms to reduce cellular cholesterol.ABC transporters help remove excess cholesterol from cells by transferring it to HDL particles.This process, known as reverse cholesterol transport, helps prevent cellular cholesterol overload.When cellular cholesterol levels are high, cells reduce LDL receptor expression to prevent further cholesterol uptake.Simultaneously, they increase the expression of ABC transporters to enhance cholesterol efflux.This coordinated response involves multiple regulatory pathways working together to maintain optimal cholesterol levels.